JCJorge Santiago López Camelo

Jorge Santiago López Camelo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jorge Santiago López Camelo has a total of 169 co-authors. Here are the top co-authors by number of shared publications:

  • Fernando Adrian Poletta

    ECLAMC at Cemic, Buenos Aires, Argentina

    11 shared publications
  • Hebe Campaña

    Laboratorio de Epidemiología Genética, Centro de Educación Médica e Investigaciones Clínicas-Consejo Nacional de Investigaciones Científicas y Técnicas (CEMIC-CONICET), Ciudad Autónoma de Buenos Aires, Argentina

    7 shared publications
  • Monica Rittler

    Laboratorio de Epidemiología Genética, Centro de Educación Médica e Investigaciones Clínicas-Consejo Nacional de Investigaciones Científicas y Técnicas (CEMIC-CONICET), Ciudad Autónoma de Buenos Aires, Argentina

    6 shared publications
  • Eduardo E. Castilla

    ECLAMC (Latin American Collaborative Study of Congenital Malformations) at CEMIC (Center for Medical Education and Clinical Research), Buenos Aires, Argentina

    5 shared publications
  • Julia Ratowiecki

    Laboratorio de Epidemiología Genética, Centro de Educación Médica e Investigaciones Clínicas‐Consejo Nacional de Investigaciones Científicas y Técnicas (CEMIC‐CONICET) Ciudad Autónoma de Buenos Aires Buenos Aires Argentina

    5 shared publications
  • Lucas Giménez

    Laboratorio de Epidemiología Genética, Centro de Educación Médica e Investigaciones Clínicas‐Consejo Nacional de Investigaciones Científicas y Técnicas (CEMIC‐CONICET) Ciudad Autónoma de Buenos Aires Buenos Aires Argentina

    5 shared publications

Latest Publications

  • Parental consanguinity and the prevalence of congenital anomalies in Venezuela: a comparative analysis with the Latin American Collaborative Study of Congenital Malformations-ECLAMC

    by Braulio Jatar Senior, Julián Negri, Jorge López Camelo

    Parental consanguinity can increase the risk of selected congenital anomalies, but its population impact depends on local marriage patterns, ancestry structure, and access to reproductive and preventive health services. We compare the prevalence of congenital anomalies in Coro (Falcón State, Venezuela) with other ECLAMC hospitals and to quantify the contribution of parental consanguinity and reproductive/sociodemographic factors to anomalies with excess prevalence in Coro. Hospital-based surveillance data from ECLAMC (2002–2024) were analyzed. Prevalence (per 10,000 births) and 95% confidence intervals were estimated for 40 anomalies among 108,380 births in Coro and 2,177,774 births in other participating hospitals. Anomalies with higher prevalence in Coro were examined using case–control analyses to estimate odds ratios, attributable risk among the exposed, and population attributable risk. To address multiple testing across 40 anomalies, P-values were additionally evaluated using the Benjamini–Hochberg false discovery rate (q = 0.05). Three anomalies showed higher prevalence in Coro: spina bifida (13.7 vs. 9.7 per 10,000), hypospadias (12.0 vs. 8.1), and postaxial polydactyly (30.5 vs. 15.8) (p < 0.01). Parental consanguinity was associated with increased risk of spina bifida and postaxial polydactyly in both settings, with a larger population attributable risk in Coro due to higher exposure frequency. In Coro, multigravidity, reduced prenatal care, and a history of fetal losses were also associated with postaxial polydactyly. Regional differences in congenital anomaly prevalence within ECLAMC partly reflect variation in parental consanguinity and reproductive factors. These findings support the integration of community genetics actions (targeted counseling, risk communication) with congenital anomaly surveillance in higher-consanguinity settings.

  • Open Access

    Ceftazidime-Avibactam Regimens for the Treatment of Bacteremic and Non-Bacteremic Episodes of Carbapenemase-Producing Enterobacterales Infections in Immunosuppressed Patients

    by Fabián Herrera, Diego Torres, María Leone, Maximiliano Gabriel Castro, Jorge López Camelo, Elena Temporiti, Natalin Grippo, Silvia Relloso, Pablo Bonvehí

    Ceftazidime-avibactam (CA) and CA plus aztreonam (ATM) are the preferred treatment options for KPC and MBL carbapenemase-producing Enterobacterales infections (CPEis). All episodes of monomicrobial CPEis in immunosuppressed patients (IPs) admitted from May 2019 to November 2024, who received definitive antibiotic therapy (AT) with CA or CA + ATM for at least 72 h, were prospectively included. Bacteremic episodes (BEs) and non-bacteremic episodes (NBEs) were compared. Logistic regressions adjusted by propensity score were used to identify variables associated with 30-day overall mortality. In total, 82 CPEis were included (38 NBEs and 44 BEs). BEs more frequently occurred in hematological malignancies (52.3% vs. 15.8%, p = 0.0006), while NBEs were more commonly observed in solid organ transplantation (73.7% vs. 34.1%, p = 0.001). K. pneumoniae was the main isolated microorganism; KPC-CPE was the most common resistance mechanism in both groups, followed by MBL-CPE. The 7-day clinical response, 30-day overall and infection-related mortality between NBEs and BEs were 92.1% vs. 88.6%, p = 0.59, 10.5% vs. 27.3%, p = 0.09, and 2.6% vs. 13.6%, p = 0.11. Septic shock, OR 6.5, 95% CI, 1.58–26.72 (p = 0.01), and refractory malignancy, OR 5.6, 95% CI, 1.03–30.14 (p = 0.046), were associated with 30-day mortality, whereas BEs were not, OR 1.5, 95% CI, 0.36–6.2 (p = 0.56). CPEis in both NBE and BE IPs who received definitive AT with CA or CA + ATM correlated with a high rate of 7-day clinical response and low 30-day infection-related mortality. Underlying malignancy and disease severity were associated with 30-day overall mortality. Regional knowledge of bacterial antibiotic resistance enables the implementation of individualized AT to improve patient survival.


  • Spatial and Temporal Analysis of Hospital Discharges due to Congenital Malformations in Argentina

    by Marcelo I. Figueroa, Lautaro D. Andrade, Jorge S. López‐Camelo, Hernán J. Dopazo, José E. Dipierri

    Background: Hospital discharges (HD) provide population data that can be used to define specific epidemiological profiles. Objectives: To quantify the prevalence of CM among all hospital discharges and its spatiotemporal patterns across Argentina. Furthermore, the study will benchmark these estimates against RENAC to contextualize agreement and discrepancies. Methods: HD data (2005–2020) from the National Ministry of Health were analyzed at national, regional, and provincial levels. We estimated the proportion of HD due to CM (HDCM; ICD‐10 Q00–Q99) overall and by age (< 1 year, 1–5 years, > 5 years). For infants < 1 year, CM prevalence per 100 live births (LB) was computed and compared with RENAC. Temporal trends were assessed with Joinpoint regression. Results: HDCM represented 0.71% of all HD; 63.4% occurred in children ≥ 1 year, indicating substantial CM‐related care beyond infancy. Spatial differences were directionally consistent across sources: nationally and in the Center, RENAC estimates were higher than HDCM; Cuyo showed higher HDCM throughout; NWA shifted to higher HDCM from mid‐decade; NEA/Patagonia displayed small gaps with occasional crossovers. Temporally, Joinpoint analyses revealed heterogeneous regional trends without a common timing of inflections: HDCM increased in NWA, the gap widened in Cuyo toward the late decade, while national and Center trajectories were relatively stable; RENAC series remained more tightly clustered around the national pattern. In infants < 1 year, structural cardiac malformations were the leading HD diagnoses. Conclusion: HD‐based metrics and RENAC provide complementary views of the CM burden; their systematic divergence with regional heterogeneity indicates that HD can robustly contextualize spatiotemporal differences where birth‐surveillance alone is insufficient.

  • Paternal age and risk for selected birth defects in a large South American sample

    by Juan A. Gili, Monica Rittler, Silvina Heisecke, Hebe Campaña, Lucas Giménez, María Rita Santos, Julia Ratowiecki, Viviana Cosentino, Jorge López Camelo, Fernando A. Poletta

    BackgroundThe relationship between maternal age (MA) and birth defects (BD) has been extensively studied while much less research, mostly with discordant results, has focused on the risk of paternal age (PA) for BD. Furthermore, no consensus has been reached on the best way to control the association of PA with MA.ObjectivesThe aim of the study was to evaluate the risk of PA increase, at 1-year intervals, for selected BD, especially controlling for the confounding effect of MA.MethodsThe sample comprised of 27,944 liveborns presenting 1 of 18 selected isolated BD. Conditional logistic regressions were applied to evaluate the risk of advanced PA and its yearly increase, adjusting by MA and other variables.ResultsOf the 18 analyzed BD, only the risk for preaxial polydactyly (PreP) showed a significant association with increasing PA, while advanced MA was of low risk. For esophageal and anal atresia, associations with both PA and MA increases were observed.ConclusionsResults support the hypothesis of advanced PA as a risk factor for PreP and helps clarify the so far unexplained nonrandom association between this defect and Down syndrome.


  • Open Access

    Gene-environment interactions and preterm birth predictors: A Bayesian network approach

    by Dario E. Elias, Maria R. Santos, Hebe Campaña, Fernando A. Poletta, Silvina L. Heisecke, Juan A. Gili, Julia Ratowiecki, Viviana R. Cosentino, Rocio Uranga, Diana Rojas Málaga, et al.

    Preterm birth (PTB) is the main condition related to perinatal morbimortality worldwide. The aim of this study was to identify gene-environment interactions associated with spontaneous PTB or its predictors. We carried out a retrospective case-control study including parental sociodemographic and obstetric data as well as newborn genetic variants of 69 preterm and 61 at term newborns born at a maternity hospital from Tucumán, Argentina, between 2005 and 2010. A data-driven Bayesian network including the main PTB predictors was created where we identified gene-environment interactions. We used logistic regressions to calculate the odds ratios and confidence intervals of the interactions. From the main PTB predictors (nine exposures and six genetic variants) we identified an interaction between low neighbourhood socioeconomic status and rs2074351 (PON1, genotype GG) variant that was associated with an increased risk of toxoplasmosis (odds ratio 12.51, confidence interval 95%: 1.71 - 91.36). The results of this exploratory study suggest that structural social disparities could influence the PTB risk by increasing the frequency of exposures that potentiate the risk associated with individual characteristics such as genetic traits. Future studies with larger sample sizes are necessary to confirm these findings.

  • A Multicountry Analysis of Prevalence and Mortality among Neonates and Children with Bladder Exstrophy

    by Vijaya Kancherla, Lucita Tandaki, Manasvi Sundar, Anke Lux, Marian K Bakker, Jorieke Eh Bergman, Eva Bermejo-Sánchez, Mark A Canfield, Marcia L Feldkamp, Boris Groisman, et al.

    Objective Bladder exstrophy (BE) is a rare but severe birth defect affecting the lower abdominal wall and genitourinary system. The objective of the study is to examine the total prevalence, trends in prevalence, and age-specific mortality among individuals with BE. Study Design We conducted a retrospective cohort study. Data were analyzed from 20 birth defects surveillance programs, members of the International Clearinghouse for Birth Defects Surveillance and Research in 16 countries. Live births, stillbirths, and elective terminations of pregnancy for fetal anomaly (ETOPFA) diagnosed with BE from 1974 to 2014. Pooled and program-specific prevalence of BE per 100,000 total births was calculated. The 95% confidence intervals (CI) for prevalence were estimated using Poisson approximation of binomial distribution. Time trends in prevalence of BE from 2000 to 2014 were examined using Poisson regression. Proportion of deaths among BE cases was calculated on the day of birth, day 2 to 6, day 7 to 27, day 28 to 364, 1 to 4 years, and ≥5 years. Mortality analysis was stratified by isolated, multiple, and syndromic case status. Results The pooled total prevalence of BE was 2.58 per 100,000 total births (95% CI = 2.40, 2.78) for study years 1974 to 2014. Prevalence varied over time with a decreasing trend from 2000 to 2014. The first-week mortality proportion was 3.5, 17.3, and 14.6% among isolated, multiple, and syndromic BE cases, respectively. The majority of first-week mortality occurred on the first day of life among isolated, multiple, and syndromic BE cases. The proportion of first-week deaths was higher among cases reported from programs in Latin America where ETOPFA services were not available. Conclusions Prevalence of BE varied by program and showed a decreasing trend from 2000 to –2014. Mortality is a concern among multiple and syndromic cases, and a high proportion of deaths among cases occurred during the first week of life. Key Points The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. This analysis has been replicated by Manasvi Sundar (Emory University). † These authors contributed equally to this work. Received: 20 July 2021 Accepted: 18 February 2022 Article published online: 29 May 2022 © 2022. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA


  • Neonatal anthropometry of malformed newborns: A large South American population‐based study

    by Silvina Heisecke, Emma L. Alfaro, Jorge Martínez, Marcelo Figueroa, Rubén Bronberg, Julia Ratowiecki, Jorge S. López Camelo, José E. Dipierri

    Background: Population‐based anthropometric evaluation of malformed newborns is scarce.Objectives: To evaluate malformed newborns' foetal growth using the ICD 10 malformations' classification.Methods: A study including 33,769 newborns (14,857 malformed and 18,912 nonmalformed), selected from 678,840 births from nine South American countries, period 2010–2018, was conducted. Prevalence of severe small and small for gestational age was calculated for malformed and nonmalformed newborns classified by preterm birth categories. Prevalence and relative risk (RR) with its 95% confidence interval (CI) were calculated. The associations between anthropometric phenotypes and congenital malformations were evaluated with generalized linear models.Results: Prevalence of preterm and term severe small and small for gestational age newborns was higher in malformed than that in nonmalformed neonates. For grouped ICD 10 malformations categories, the RR for severe small for gestational age was 2.88 (95% CI 2.51, 3.30) and 2.10 (95% CI 1.92, 2.30) for small for gestational age. For at‐term and preterm malformed newborns, the RR for severe small for gestational age was 2.21 (95% CI 1.87, 2.61) and 3.21 (95% CI 2.52, 4.10), respectively; for small for gestational age, the RR was 2.31 (95% CI 2.11, 2.53) for at‐term newborns and 2.58 (95% CI 2.16, 3.08) for preterm ones.Conclusions: Prevalence and relative risk of severe small and small for gestational age vary according to the group of malformations and gestational age; they increase in congenital malformations of the nervous, respiratory and digestive systems, and in chromosomal abnormalities and are lower for malformations of eye, ear, face and neck and cleft lip and palate. Foetal growth considered together with malformed newborns' gestational age would allow for inferring different risks of morbidity and mortality.


  • Open Access

    Diseases during pregnancy in a large unselected South American sample

    by María Rita Santos, Hebe Campaña, Silvina Heisecke, Julia Ratowiecki, Darío Elías, Lucas Giménez, Fernando Adrián Poletta, Juan Gili, Rocío Uranga, Viviana Cosentino, et al.

    Objective: Our aim was to describe the prevalence of diseases during pregnancy and the association between fetal exposure to the most frequent maternal diseases and the risk of preterm (PTB) and/or small for gestational age (SGA) newborns in an unselected sample of women who gave birth in South American countries. Methods: We conducted a descriptive, cross-sectional study including 56,232 mothers of non-malformed infants born between 2002 and 2016, using data from the Latin American Collaborative Study of Congenital Malformations (ECLAMC). Diseases with higher- than-expected PTB/SGA frequencies were identified. Odds ratios of confounding variables for diseases and birth outcomes were calculated with a multivariable logistic regression. Results: Of the 14 most reported diseases, hypertension, genitourinary infection, epilepsy, hypothyroidism, diabetes, and HIV/AIDS showed higher PTB and/or SGA frequencies. Advanced and low maternal age, previous fetal loss, low socioeconomic level, and African-American ancestry were associated with PTB, while advanced maternal age, primigravidity, previous fetal loss, low socioeconomic level, and African-American ancestry were associated with SGA. After adjusting for the associated variables, the identified illnesses maintained their association with PTB and all, except epilepsy, with SGA. Conclusion: The description of an unselected population of mothers allowed identifying the most frequent diseases occurring during gestation and their impact on pregnancy outcomes. Six diseases were associated with PTB and two with SGA newborns. To the best of our knowledge, there are no similar reports about women not intentionally selected by specific diseases during pregnancy in South American populations.


  • Lethality of Birth Defects in Live Born Infants Categorized by Gestational Age and Birth Weight

    by Monica Rittler, Hebe Campaña, Silvina Heisecke, Julia Ratowiecki, Dario Elias, Lucas Gimenez, Fernando A. Poletta, Juan Gili, Mariela Pawluk, Maria Rita Santos, et al.

    Objective This study aimed to describe lethality of birth defects (BDs) in newborns categorized by gestational age and birth weight and to identify BDs associated with prematurity. Study Design Live born infants (n = 16,452) with isolated BDs classified by severity, and 42,511 healthy controls were assigned to categories: adequate growth, preterm, or small for gestational age (SGA). Proportion of cases and BDs' lethality rates were obtained by category and compared with controls. Results Overall fewer malformed than nonmalformed infants were of adequate growth, while the opposite occurred in the preterm and SGA categories where gastroschisis and esophageal atresia were among the most outstanding defects. For most severe BDs, the early neonatal death rate was higher than control values in all categories; for mild defects, except cleft lip in the preterm category, they did not differ. Diaphragmatic hernia showed the highest lethality values, while those of spina bifida were among the lowest. Talipes, hypospadias, and septal heart defects were mild defects significantly associated with prematurity. Conclusion Although reasons, such as induced preterm delivery of fetuses with certain anomalies, could partially account for their high prematurity rates, susceptibility to preterm birth might exist through underlying mechanisms related with the defects. The identification of BDs associated with prematurity should serve to improve measures that prevent preterm birth especially of fetuses at risk. Key Points


  • The Latin American network for congenital malformation surveillance: ReLAMC

    by Iêda Maria Orioli, Helen Dolk, Jorge Lopez‐Camelo, Boris Groisman, Adriana Benavides‐Lara, Lucas Gabriel Gimenez, Daniel Mattos Correa, Marta Ascurra, Eliana de Aquino Bonilha, Maria Aurora Canessa‐Tapia, et al.

    The early detection of congenital anomaly epidemics occurs when comparing current with previous frequencies in the same population. The success of epidemiologic surveillance depends on numerous factors, including the accuracy of the rates available in the base period, wide population coverage, and short periodicity of analysis. This study aims to describe the Latin American network of congenital malformation surveillance: ReLAMC, created to increase epidemiologic surveillance in Latin America. We describe the main steps, tasks, strategies used, and preliminary results. From 2017 to 2019, five national registries (Argentina [RENAC], Brazil [SINASC/SIM‐BRS], Chile [RENACH], Costa Rica [CREC], Paraguay [RENADECOPY‐PNPDC]), six regional registries (Bogotá [PVSDC‐Bogota], Cali [PVSDC‐Cali], Maule [RRMC SSM], Nicaragua [SVDC], Nuevo‐León [ReDeCon HU], São Paulo [SINASC/SIM‐MSP]) and the ECLAMC hospital network sent data to ReLAMC on a total population of 9,152,674 births, with a total of 101,749 malformed newborns (1.1%; 95% CI 1.10–1.12). Of the 9,000,651 births in countries covering both live and stillbirths, 88,881 were stillborn (0.99%; 95% CI 0.98–0.99), and among stillborns, 6,755 were malformed (7.61%; 95% CI 7.44–7.79). The microcephaly rate was 2.45 per 10,000 births (95% CI 2.35–2.55), hydrocephaly 3.03 (2.92–3.14), spina bifida 2.89 (2.78–3.00), congenital heart defects 15.53 (15.27–15.79), cleft lip 2.02 (1.93–2.11), cleft palate and lip 2.77 (2.66–2.88), talipes 2.56 (2.46–2.67), conjoined twins 0.16 (0.14–0.19), and Down syndrome 5.33 (5.18–5.48). Each congenital anomaly showed heterogeneity in prevalence rates among registries. The harmonization of data in relation to operational differences between registries is the next step in developing the common ReLAMC database.